21/08/2025
CSCRI appreciated the opportunity to talk to Nigel Dalton, State Government Member for Mackay, about the event CSCRI is hosting tonight where Dr Paul Wagner from US-based Forte Biosciences is guest speaker, and sharing encouraging results from their phase 1 coeliac disease study. We also shared how CSCRI's clinical trial delivery model could improve healthcare outcomes for regional Queensland, increasing access to clinical trials for regional, rural and remote communities.
🚀 Mackay keeps making history!
Tonight I heard from Dr Paul Wagner, CEO of US-based Forte Biosciences, who shared the exciting results of their Phase 1 coeliac disease trial.
The big news? They’ve chosen Sea Clinical Research Institute (CSCRI) for their Phase 2 study — thanks to CSCRI’s ability to connect with patients in regional communities and Dr James Daveson’s world-class reputation in coeliac research.
🌏 Another global first for Mackay!